Phibro Animal Health (PAHC) Q2 2024 Annual Earnings
PAHC·Reported August 28, 2024·After market close
Phibro Animal Health reported Q2 2024 revenue of $273.2M, beat analyst consensus of $263.2M by $9.9M. Diluted EPS came in at $0.41, beat the $0.34 consensus by $0.07.
Revenue
$273.2Mbeat by $9.9M
Consensus: $263.2MDiluted EPS
$0.41beat by $0.07
Consensus: $0.34
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Phibro Animal Health's Q2 2024 earnings report.
Phibro Animal Health (PAHC) reported Q2 2024 earnings on August 28, 2024 after market close.
Phibro Animal Health reported revenue of $273.2M and diluted EPS of $0.41 for Q2 2024.
Revenue beat the consensus estimate of $263.2M by $9.9M. EPS beat the consensus estimate of $0.34 by $0.07.
You can read the 10-K periodic report (0001558370-24-012517) directly on SEC EDGAR. The filing index links above go to sec.gov.